Suppr超能文献

Intravenous pamidronate for myeloma bone disease: can the dose be lowered?

作者信息

Terpos Evangelos, Dimopoulos Meletios A

出版信息

Lancet Oncol. 2010 Oct;11(10):913-4. doi: 10.1016/S1470-2045(10)70227-8.

Abstract
摘要

相似文献

1
Intravenous pamidronate for myeloma bone disease: can the dose be lowered?
Lancet Oncol. 2010 Oct;11(10):913-4. doi: 10.1016/S1470-2045(10)70227-8.
3
Zoledronic acid in myeloma: MRC Myeloma IX.
Lancet. 2010 Dec 11;376(9757):1965-6. doi: 10.1016/S0140-6736(10)62178-2. Epub 2010 Dec 3.
4
Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma.
Bone Marrow Transplant. 2015 Jan;50(1):157. doi: 10.1038/bmt.2014.225. Epub 2014 Oct 13.
8
The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
Oncol Nurs Forum. 2005 Nov 3;32(6):E127-38. doi: 10.1188/05.ONF.E127-E138.
9
Stem cell transplantation in multiple myeloma.
Lancet Oncol. 2017 May;18(5):e252. doi: 10.1016/S1470-2045(17)30276-0. Epub 2017 Apr 13.
10
The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.
Eur J Haematol. 2012 Jan;88(1):1-7. doi: 10.1111/j.1600-0609.2011.01721.x. Epub 2011 Nov 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验